In this podcast series Dr. Rishi Singh will be talking with:

• Dr. Andrew Moshfeghi on Current Insights into Anti-VEGF use in Diabetic Retinopathy;
• Dr. Dilsher Dhoot on how to address the treatment burden in nAMD as a provider;
• Dr. Ted Leng on how to address the treatment burden in nAMD with patients;
• Dr. Nathan Steinle on real world applications for dosing strategies in nAMD;
• Dr. Nancy Holekamp on drug delivery in neovascular retinal disease; and with
• Dr. Arshad Khanani on targeting treatment in neovascular retinal disease

We encourage you to take 12 to 15 minutes out of your day to hear these updates on neovascular retinal diseases